Elevance Health ELV Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $50.18B+0.9% | $49.75B-1.9% | $50.71B+1.9% | $49.78B+1.8% | $48.89B+7.6% | ||
| $5.46B-1.1% | $5.52B+2.6% | $5.38B+1.6% | $5.29B+6.2% | $4.98B-17.1% | ||
| $44.72B+1.1% | $44.23B-2.4% | $45.33B+1.9% | $44.48B+1.3% | $43.91B+11.4% | ||
| 89.1%+0.2pp | 88.9%-0.5pp | 89.4%0.0pp | 89.4%-0.4pp | 89.8%+3.0pp | ||
| $6.33B+16.9% | $5.42B+2.7% | $5.27B+5.5% | $5B-5.7% | $5.3B+10.3% | ||
| $357M-2.5% | $366M+4.3% | $351M+2.9% | $341M-0.9% | $344M+1.2% | ||
| $2.3B+972% | $215M-84.7% | $1.41B-38.7% | $2.29B-18.1% | $2.8B+362% | ||
| $544M— | —— | $219M-60.0% | $548M-10.6% | $613M+218% | ||
| $1.76B+222% | $547M-54.0% | $1.19B-31.8% | $1.74B-20.2% | $2.18B+422% | ||
| 3.5%+2.4pp | 1.1%-1.2pp | 2.3%-1.2pp | 3.5%-1.0pp | 4.5%+3.5pp | ||
| $8.00+215% | $2.54-52.3% | $5.32-31.1% | $7.72-19.7% | $9.61+414% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Elevance Health's revenue?
- Elevance Health (ELV) generated $200.42B in revenue over the trailing twelve months, up 9.3% year over year.
- Is Elevance Health profitable?
- Elevance Health reported $5.2B in net income over the trailing twelve months, a 2.6% net margin.
- What is Elevance Health's earnings per share?
- Elevance Health's diluted EPS over the trailing twelve months is $23.58.
- Where does Elevance Health's income statement data come from?
- Every line is extracted from Elevance Health's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
